In conclusion, this study provides evidence that rare and low-frequency coding variants associated with adult-onset MS (PRF1) and within the MHC region (BRD2 and AGER) are associated with POMS susceptibility. The gene discussed is BRD2; the disease is myeloid sarcoma.